AI in Oncology Survey

The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below.

I am a 4th year pharmacy student at Kingston University currently conducting a research project on the use of artificial intelligence (AI) within oncology. My study focuses on understanding how AI technologies are being developed and implemented to improve cancer care, from early diagnosis and treatment planning to patient monitoring and drug development. Through this research, I aim to explore how these advancements will influence the future of pharmacy practice, and to understand its impact on both clinical decision-making and the wider healthcare system.

I am conducting a study on artificial intelligence (AI) in oncology pharmacy and would value your input as a pharmacy professional.

Why participate?

  •      Help shape understanding of AI in oncology pharmacy practice
  •      Share your experiences, opinions, and insights
  •      Contribute to research that may improve patient care and pharmacy workflows

Survey details:

  •      Time: ~10 minutes
  •      Who: All BOPA members (pharmacists, technicians, academics, pharmacy assistants)
  •      Confidentiality: Responses are anonymous and voluntary
  •      Consent: Submission of the survey indicates your consent to participate

Survey link: AI use within Oncology  – Fill in form

An information sheet is within the link with further details. For questions, contact Erona Kaqiju at [email protected].

Thank you for helping us explore the role of AI in oncology pharmacy — your views are valuable!

 

Kind regards,

Erona Kaqiju

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article